UTEP student develops award-winning method to desalinate water
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Apr-2025 15:08 ET (29-Apr-2025 19:08 GMT/UTC)
Tayia Oddonetto, a doctoral student in environmental science and engineering at The University of Texas at El Paso, developed electrodialysis metathesis, a novel approach to the desalination of brine, or salt, water that can convert over 90% of salt water to fresh water. The research earned Oddonetto first place and funding from the National Science Foundation Engineering Research Centers Perfect Pitch Competition.
University of Texas at Dallas mechanical engineers have designed a 3D-printed femur that could help doctors prepare for surgeries to repair bones and develop treatments for bone tumors.
The engineers, who worked in collaboration with UT Southwestern Medical Center orthopedic surgeons, published their first study on the 3D-printed thigh bone online Aug. 5 in the Journal of Orthopaedic Research.
The study, which focused on the middle section of the bone, establishes 3D-printing parameters for a femur for use in biomechanical testing. Researchers said more studies will be needed before the technology could be available for widespread use.
The Skin Aging and Challenges 2024 conference will bring together leading scientists and researchers to explore the latest advancements in skin health, anti-aging, and cellular rejuvenation. Central themes include cellular senescence, mitochondrial function, microbiota's influence, and iron regulation, each with significant implications for delaying or reversing skin aging.
A key highlight is the exploration of exosomes, tiny extracellular vesicles emerging as potential carriers of regenerative compounds, which offer promising avenues for skin rejuvenation. Experts will discuss how exosomes may help deliver targeted treatments to reverse cellular aging and improve skin elasticity and repair.
Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS).
Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. The results were also published simultaneously in the Journal of the American College of Cardiology.
The EVOLVED trial found that early aortic valve intervention in patients with asymptomatic severe aortic stenosis (AS) and mid-wall myocardial fibrosis on magnetic resonance imaging did not reduce the incidence of the composite primary endpoint of all-cause death or unplanned aortic stenosis hospitalization compared with guideline-directed conservative management.
Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. The results were also published simultaneously in the Journal of the American Medical Association
The first powered randomized trial examining early intervention with transcatheter aortic valve replacement (TAVR) in patients with asymptomatic, severe aortic stenosis (AS) found this strategy to be both a safe and effective alternative to clinical surveillance (CS).
Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine. Results were also published simultaneously in the New England Journal of Medicine.